Capricor Therapeutics, Inc. (CAPR)

NMS – Real Time Price. Currency in USD

4.16

+0.23 (5.73%)

Market open: Aug 12, 2026, 3:35 PM EDT

3.94

+0.01 (0.25%)

Previous after-hours: Aug 11, 2026, 7:56 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

22M

25M

Cost of goods sold

-2M

-1M

-695K

Gross Profit

-2M

21M

24M

Operating expenses (excl. COGS)

-106M

-63M

-48M

-32M

Operating Income

-108M

-43M

-24M

-30M

Non-operating income, total

678K

Pretax income

-105M

-40M

-22M

-29M

Equity in earnings

Taxes

-2K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-105M

-40M

-22M

-29M

Discontinued operations

Net income

-105M

-40M

-22M

-29M

Dilution adjustment

Preferred dividends

Capricor Therapeutics, Inc. (CAPR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Capricor Therapeutics, Inc. (CAPR)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Capricor Therapeutics, Inc. (CAPR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Capricor Therapeutics, Inc. (CAPR)

Income Statement (Annual)

Income Statement (Annual)